Evaluating Toxicity Considerations & Challenges for Next-Generation ADC Payloads & Design

9:30 am - Monday 23rd February 2026

  • Contextualising the field’s prioritisation of novel ADC payloads and design in next-generation ADC development
  • Understanding toxicity challenges and opportunities for novel and dual payload ADCs
  • Exploring ongoing development, promise and opportunities of bispecific ADC programmes

Speakers:

Chief Scientific Officer
Bionavigen Oncology